Gabriël E. Jacobs

884 total citations
40 papers, 616 citations indexed

About

Gabriël E. Jacobs is a scholar working on Cellular and Molecular Neuroscience, Cognitive Neuroscience and Experimental and Cognitive Psychology. According to data from OpenAlex, Gabriël E. Jacobs has authored 40 papers receiving a total of 616 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cellular and Molecular Neuroscience, 14 papers in Cognitive Neuroscience and 12 papers in Experimental and Cognitive Psychology. Recurrent topics in Gabriël E. Jacobs's work include Treatment of Major Depression (9 papers), Neurotransmitter Receptor Influence on Behavior (8 papers) and Sleep and related disorders (7 papers). Gabriël E. Jacobs is often cited by papers focused on Treatment of Major Depression (9 papers), Neurotransmitter Receptor Influence on Behavior (8 papers) and Sleep and related disorders (7 papers). Gabriël E. Jacobs collaborates with scholars based in Netherlands, United States and Belgium. Gabriël E. Jacobs's co-authors include Joop van Gerven, Rob Zuiker, Wayne C. Drevets, Adam F. Cohen, Luc Van Nueten, Peter de Boer, Peter van der Ark, Marieke de Kam, R. Luthringer and Justine Kent and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and Scientific Reports.

In The Last Decade

Gabriël E. Jacobs

38 papers receiving 596 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gabriël E. Jacobs Netherlands 16 230 179 139 136 130 40 616
Andrea Rotter Germany 17 123 0.5× 82 0.5× 97 0.7× 96 0.7× 116 0.9× 21 661
Yi‐Qun Wang China 16 413 1.8× 207 1.2× 35 0.3× 225 1.7× 164 1.3× 29 826
Natalia Gass Germany 17 365 1.6× 62 0.3× 154 1.1× 30 0.2× 240 1.8× 30 699
Andréia Silva da Rocha Brazil 14 93 0.4× 40 0.2× 111 0.8× 40 0.3× 144 1.1× 22 534
Takenori Okumura Japan 16 58 0.3× 79 0.4× 84 0.6× 128 0.9× 217 1.7× 25 633
Carrie L. Wade United States 12 114 0.5× 65 0.4× 113 0.8× 65 0.5× 557 4.3× 15 1.0k
Tomoko Tsunoka Japan 16 60 0.3× 81 0.5× 84 0.6× 129 0.9× 221 1.7× 24 666
L. Demisch Germany 19 176 0.8× 110 0.6× 99 0.7× 126 0.9× 200 1.5× 55 920
Péter Petschner Hungary 15 57 0.2× 68 0.4× 81 0.6× 52 0.4× 120 0.9× 50 652
Francesca Regen Germany 15 281 1.2× 185 1.0× 244 1.8× 49 0.4× 97 0.7× 44 1.0k

Countries citing papers authored by Gabriël E. Jacobs

Since Specialization
Citations

This map shows the geographic impact of Gabriël E. Jacobs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gabriël E. Jacobs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gabriël E. Jacobs more than expected).

Fields of papers citing papers by Gabriël E. Jacobs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gabriël E. Jacobs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gabriël E. Jacobs. The network helps show where Gabriël E. Jacobs may publish in the future.

Co-authorship network of co-authors of Gabriël E. Jacobs

This figure shows the co-authorship network connecting the top 25 collaborators of Gabriël E. Jacobs. A scholar is included among the top collaborators of Gabriël E. Jacobs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gabriël E. Jacobs. Gabriël E. Jacobs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schoones, Jan W., et al.. (2025). Clinical Pharmacokinetics of Psilocin After Psilocybin Administration: A Systematic Review and Post-Hoc Analysis. Clinical Pharmacokinetics. 64(1). 53–66. 1 indexed citations
2.
Zuiker, Rob, Christopher Bryan, Nancy L. Stewart, et al.. (2025). Safety, Pharmacokinetics, and Pharmacodynamics of a 6‐h N,N‐Dimethyltryptamine (DMT) Infusion in Healthy Volunteers: A Randomized, Double‐Blind, Placebo‐Controlled Trial. Clinical and Translational Science. 18(5). e70234–e70234. 1 indexed citations
3.
Marek, Gerard J., Daniel Umbricht, Edward P. Christian, et al.. (2025). A novel psychedelic 5-HT 2A receptor agonist GM-2505: The pharmacokinetic, safety, and pharmacodynamic profile from a randomized trial healthy volunteer. Journal of Psychopharmacology. 4126427472–4126427472. 1 indexed citations
4.
Kam, Marieke L. de, et al.. (2023). Item response theory in early phase clinical trials: Utilization of a reference model to analyze the Montgomery‐Åsberg Depression Rating Scale. CPT Pharmacometrics & Systems Pharmacology. 12(10). 1425–1436. 1 indexed citations
5.
Boer, Peter de, Peter van der Ark, Heike Beneš, et al.. (2023). Characterization of the central nervous system penetrant and selective purine P2X7 receptor antagonist JNJ-54175446 in patients with major depressive disorder. Translational Psychiatry. 13(1). 266–266. 36 indexed citations
6.
Londen, Liesbeth van, Vasileios Exadaktylos, Adam F. Cohen, et al.. (2023). A smartphone- and wearable-based biomarker for the estimation of unipolar depression severity. Scientific Reports. 13(1). 18844–18844. 2 indexed citations
7.
O’Donnell, Patricio, Erica S. Klaassen, Derek L. Buhl, et al.. (2022). Central nervous system effects of TAK-653, an investigational alpha-amino-3-hydroxy-5-methyl-4-isoxazole receptor (AMPAR) positive allosteric modulator in healthy volunteers. Translational Psychiatry. 12(1). 408–408. 17 indexed citations
8.
Pereira, D., et al.. (2021). MTORC1 signaling as a biomarker in major depressive disorder and its pharmacological modulation by novel rapid-acting antidepressants. SHILAP Revista de lepidopterología. 11. 1926954126–1926954126. 15 indexed citations
9.
Jacobs, Gabriël E., et al.. (2021). Predictive performance of parent-metabolite population pharmacokinetic models of (S)-ketamine in healthy volunteers. European Journal of Clinical Pharmacology. 77(8). 1181–1192.
10.
11.
Drukarch, Benjamin, Gabriël E. Jacobs, & Micha M.M. Wilhelmus. (2020). Solving the crisis in psychopharmacological research: Cellular-membrane(s) pharmacology to the rescue?. Biomedicine & Pharmacotherapy. 130. 110545–110545. 5 indexed citations
12.
Salvadore, Giacomo, Pascal Bonaventure, Anantha Shekhar, et al.. (2020). Translational evaluation of novel selective orexin-1 receptor antagonist JNJ-61393215 in an experimental model for panic in rodents and humans. Translational Psychiatry. 10(1). 308–308. 31 indexed citations
13.
Boer, Peter de, Rob Zuiker, R. Luthringer, et al.. (2019). The selective orexin-2 antagonist seltorexant (JNJ-42847922/MIN-202) shows antidepressant and sleep-promoting effects in patients with major depressive disorder. Translational Psychiatry. 9(1). 216–216. 65 indexed citations
14.
Bosman, Renske C., Ruth C. Waumans, Gabriël E. Jacobs, et al.. (2018). Failure to Respond after Reinstatement of Antidepressant Medication: A Systematic Review. Psychotherapy and Psychosomatics. 87(5). 268–275. 14 indexed citations
15.
Meng, Jianjun, et al.. (2018). A Study of the Effects of Electrode Number and Decoding Algorithm on Online EEG-Based BCI Behavioral Performance. Frontiers in Neuroscience. 12. 227–227. 17 indexed citations
16.
Jacobs, Gabriël E., et al.. (2018). Subanesthetic Dose Ketamine in Posttraumatic Stress Disorder: A Role for Reconsolidation During Trauma-Focused Psychotherapy?. Current topics in behavioral neurosciences. 38. 137–162. 19 indexed citations
17.
18.
Chen, Xia, Joop van Gerven, Adam F. Cohen, & Gabriël E. Jacobs. (2018). Human pharmacology of positive GABA-A subtype-selective receptor modulators for the treatment of anxiety. Acta Pharmacologica Sinica. 40(5). 571–582. 39 indexed citations
19.
Ewijk, Catharina E van, Gabriël E. Jacobs, & Armand R. J. Girbes. (2016). Unsuspected serotonin toxicity in the ICU. Annals of Intensive Care. 6(1). 85–85. 15 indexed citations
20.
Chen, Xia, Gabriël E. Jacobs, Marieke L. de Kam, et al.. (2014). AZD6280, a Novel Partial γ-Aminobutyric Acid A Receptor Modulator, Demonstrates a Pharmacodynamically Selective Effect Profile in Healthy Male Volunteers. Journal of Clinical Psychopharmacology. 35(1). 22–33. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrea Rotter Breakdown of academic impact, for papers by Yi‐Qun Wang Breakdown of academic impact, for papers by Natalia Gass Breakdown of academic impact, for papers by Andréia Silva da Rocha Breakdown of academic impact, for papers by Takenori Okumura Breakdown of academic impact, for papers by Carrie L. Wade Breakdown of academic impact, for papers by Tomoko Tsunoka Breakdown of academic impact, for papers by L. Demisch Breakdown of academic impact, for papers by Péter Petschner Breakdown of academic impact, for papers by Francesca Regen
Rankless by CCL
2026